Dear all,
is anybody aware of any regulatory (or other) guidelines (ICH, CPMP, EMEA, FDA, etc) regarding 2x2 factorial designs and their possible use for the simultaneous assessment of the efficacy of two agents. I do not mean bioequivalence trials or stability testing where apparently these are used as well.
Many thanks in advance.
With kind regards
Markus
|